Endocrine System Diseases  >>  Invokana (canagliflozin)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe
NCT02681497: Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting

Completed
N/A
269
Canada
Lawson Health Research Institute, Janssen Inc.
Type 2 Diabetes Mellitus
07/16
07/16
CRATOS, NCT02737657: An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During Ramadan

Completed
N/A
379
RoW
Janssen-Cilag International NV
Diabetes Mellitus, Type 2
09/16
09/16
CanCARE, NCT02688075: An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada

Completed
N/A
538
Canada
No Intervention
Janssen Inc.
Diabetes Mellitus, Type 2
08/17
08/17

Download Options